Table 2 Clinical characteristics of CTS patient and control subjects
Clinical data | CTS group (100 patients–142 hands) | Control group (50 subject–71 hands) | T | p |
|---|---|---|---|---|
Women (no. and %) | 84 (84%) | 40(80%) | 0.610 | 0.543 |
Age (years) mean±SD | 37.66±8.8 (18–60) | 35.08±11.42 (18–61) | 1.528 | 0.128 |
Disease duration (months) | 5.8± 2.1 (4–9) | NA | NA | NA |
Bilateral/unilateral | 42 (42%)/58 (58%) | 21 (42%)/29 (58%) | 1.00 | <0.0001 |
Side (right/left) | 80 (56.3%)/62 (43.6%) | 49 (69%)/22 (31%) | 1.788 | 0.075 |
Nocturnal/activity-related pain limited to the hand | 97 (69%)/45 (31.7%) | NA | NA | NA |
Sensory deficit in median distribution | 76 (53.5%) | NA | NA | NA |
Isolated atrophy of thenar muscle | 0 | NA | NA | NA |
Positive phalen’s or tinel’s signs | 92 (64.8)/54 (38.02%) | NA | NA | NA |